Skip to main content
. 2021 Oct 20;2021(10):CD011723. doi: 10.1002/14651858.CD011723.pub2

Comparison 2. Mindfulness versus other treatments.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Continuous abstinence at post‐treatment 1 286 Risk Ratio (M‐H, Random, 95% CI) 0.80 [0.45, 1.44]
2.2 Continuous abstinence at follow‐up 1 286 Risk Ratio (M‐H, Random, 95% CI) 0.57 [0.28, 1.16]
2.3 Percentage days with substance use at post‐treatment 5 523 Std. Mean Difference (IV, Random, 95% CI) ‐0.21 [‐0.45, 0.03]
2.4 Percentage days with substance use at follow‐up 3 409 Std. Mean Difference (IV, Random, 95% CI) ‐0.39 [‐0.96, 0.17]
2.5 Consumed amount at post‐treatment 1 25 Std. Mean Difference (IV, Random, 95% CI) ‐0.42 [‐1.23, 0.39]
2.6 Craving intensity at post‐treatment 9   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.7 Craving intensity at follow‐up 4   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.8 Treatment acceptability (attrition) 14 1531 Risk Ratio (M‐H, Random, 95% CI) 1.06 [0.89, 1.26]
2.9 Treatment acceptability (attrition): sensitivity analysis (fixed effects model) 14 1531 Risk Ratio (M‐H, Fixed, 95% CI) 1.07 [0.91, 1.25]